| 제품명 | Dapagliflozin |
|---|---|
| CAS 번호 | 461432-26-8 |
| 분자식 | C21H25ClO6 |
| 분자량 | 408.87 |
| 외관 | 흰색에서 미백색의 결정성 분말 |
| 분석법 (HPLC) | ≥98% |
| 건조 손실 | ≤0.5% |
| 소각 잔류물 | ≤0.1% |
| 중금속 | ≤10 ppm |
| 융점 | 196-200°C |
| 특정 회전 | [α]D20 = +30° to +34° (c=1, methanol) |
도움이 필요하신가요? 저희 팀에 문의해 주세요
동의어
- Dapagliflozin propanediol, BMS-512148, Farxiga, Forxiga, (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
Dapagliflozin is one of the most prescribed SGLT2 inhibitors worldwide — and for good reason. It works by blocking glucose reabsorption in the kidneys, letting excess sugar flush out through urine. That mechanism not only lowers blood glucose in type 2 diabetes patients but also delivers bonus effects like modest weight loss and blood pressure reduction. For formulators, it’s a solid choice for building combination therapies or standalone products in the fast-growing diabetes and metabolic health market.
We supply dapagliflozin as a high-purity crystalline powder, manufactured under controlled conditions and rigorously tested. Every batch is shipped with a full COA, and we offer flexible quantities — from R&D samples to bulk production — with reliable global logistics.
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese